| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.9B | $2.0B | $1.8B | $1.6B | $1.5B | $1.4B |
| Cost of Revenue | $5.4B | $5.6B | $6.4B | $6.5B | $5.6B | $4.7B | $4.9B | $4.5B |
| Gross Profit | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.4B | $0.3B | $0.3B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $0.9B | $1.0B | $0.8B | $0.3B | $0.6B | $0.7B | $0.7B |
| Net Income | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $2.59 | $1.46 | $2.00 | $1.73 | $1.00 | $1.71 | $1.63 | $1.38 |
| EPS (Diluted) | $2.56 | $1.43 | $1.97 | $1.71 | $0.99 | $1.70 | $1.61 | $1.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.9B | $7.4B | $7.6B | $7.6B | $7.0B | $6.9B | $6.0B | $5.7B |
| Current Assets | $3.5B | $3.4B | $3.4B | $3.3B | $2.7B | $2.6B | $2.2B | $2.1B |
| Cash & Equivalents | $1.0B | $1.0B | $0.4B | $0.2B | $0.3B | $0.7B | $0.3B | $0.3B |
| Total Liabilities | $3.5B | $3.6B | $4.0B | $4.3B | $3.8B | $3.8B | — | — |
| Current Liabilities | $1.3B | $1.3B | $1.8B | $1.9B | $1.5B | $1.5B | $1.0B | $0.9B |
| Stockholders' Equity | $4.3B | $3.8B | $3.5B | $3.1B | $3.1B | $3.0B | $2.7B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $1.4B | $1.1B | $0.2B | $0.4B | $0.8B | $0.7B | $0.7B |
| Investing Cash Flow | $-0.4B | $-0.0B | $-0.3B | $-0.3B | $-0.3B | $-0.6B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B |
| Financing Cash Flow | $-0.5B | $-0.8B | $-0.6B | $0.1B | $-0.4B | $0.1B | $-0.4B | $-0.6B |